- Home
- COEP vs CODA Comparison
COEP vs CODA Comparison
Compare COEP & CODA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COEP
- CODA
- Stock Information
- Founded
- COEP 2017
- CODA 1994
- Country
- COEP United States
- CODA United States
- Employees
- COEP N/A
- CODA N/A
- Industry
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- CODA Industrial Machinery/Components
- Sector
- COEP Health Care
- CODA Industrials
- Exchange
- COEP Nasdaq
- CODA Nasdaq
- Market Cap
- COEP 86.0M
- CODA 88.8M
- IPO Year
- COEP N/A
- CODA N/A
- Fundamental
- Price
- COEP $15.29
- CODA $9.95
- Analyst Decision
- COEP
- CODA Strong Buy
- Analyst Count
- COEP 0
- CODA 1
- Target Price
- COEP N/A
- CODA $11.00
- AVG Volume (30 Days)
- COEP 66.5K
- CODA 77.2K
- Earning Date
- COEP 11-12-2025
- CODA 09-15-2025
- Dividend Yield
- COEP N/A
- CODA N/A
- EPS Growth
- COEP N/A
- CODA 15.09
- EPS
- COEP N/A
- CODA 0.30
- Revenue
- COEP $263,555.00
- CODA $24,347,217.00
- Revenue This Year
- COEP N/A
- CODA $30.82
- Revenue Next Year
- COEP N/A
- CODA $20.84
- P/E Ratio
- COEP N/A
- CODA $33.27
- Revenue Growth
- COEP N/A
- CODA 29.34
- 52 Week Low
- COEP $2.31
- CODA $5.76
- 52 Week High
- COEP $19.19
- CODA $10.00
- Technical
- Relative Strength Index (RSI)
- COEP 49.85
- CODA 71.09
- Support Level
- COEP $14.90
- CODA $8.45
- Resistance Level
- COEP $16.17
- CODA $9.49
- Average True Range (ATR)
- COEP 1.17
- CODA 0.49
- MACD
- COEP -0.30
- CODA 0.10
- Stochastic Oscillator
- COEP 11.94
- CODA 97.21
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.
About CODA Coda Octopus Group Inc. Common stock
Coda Octopus Group Inc develops underwater technologies and equipment for imaging, mapping defense, and survey applications. The company's operations are organized into two reportable segments: the Products Segment (Marine Technology Business serving the subsea market and PAL, which sells other products (acoustic hydrophones and acoustic materials to a different market); and the Services Segment (Marine Engineering Business). Its geographical segments are the Americas, Europe, Australia/Asia, and the Middle East/Africa. The majority of revenue is derived from the Products segment.